• Lindex won on all central issues today in an appeals court ruling over Essity’s challenge to its period underwear marketing.
• The court ordered Essity to reimburse all litigation costs, finding no proof that light urinary leakage marketing concerned disease or disability.
• Essity sued in 2024, alleging unfair marketing and arguing the products required classification as medical devices subject to CE marking.
• On May 21, 2025, the lower court rejected most claims but prohibited certain statements about competing incontinence products.
• That ruling awarded Lindex 4.69 million kronor in legal costs, with interest.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB Lindex published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.